Psychedelic medicine and cultural responsiveness: A call for Aboriginal and Torres Strait Islander engagement in Australian clinical trials and practice

Affiliations

• ¹ IPAT (Indigenous Psychedelic Assisted Therapies) Organisation, Australia; Psychedelic Medicine and Supportive Care Lab, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. Electronic address: Bianca.Sebben@qimrberghofer.edu.au.
• ² IPAT (Indigenous Psychedelic Assisted Therapies) Organisation, Australia; We Al-Li Organisation, Australia.
• ³ Psychae Institute, Melbourne, Australia; Centre for Mental Health, Swinburne University of Technology, Melbourne, Australia; The Florey Institute of Neuroscience and Mental Health & The Department of Psychiatry, Melbourne University, Melbourne, Australia; NICM Health Research Institute, Western Sydney University, Westmead, NSW, Australia.
• ⁴ Psychae Institute, Melbourne, Australia; Centre for Mental Health, Swinburne University of Technology, Melbourne, Australia; School of Population and Global Health, University of Melbourne, Melbourne, Australia.
• ⁵ IPAT (Indigenous Psychedelic Assisted Therapies) Organisation, Australia; Psychedelic Medicine and Supportive Care Lab, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
• ⁶ IPAT (Indigenous Psychedelic Assisted Therapies) Organisation, Australia; Indigenous Strategy Department, University of Melbourne, Melbourne, Australia.
• ⁷ Psychae Institute, Melbourne, Australia; School of Population and Global Health, University of Melbourne, Melbourne, Australia; Onaya Science, Iquitos, Peru.
• ⁸ Psychedelic Medicine and Supportive Care Lab, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; School of Psychology, The University of Queensland, Brisbane, Queensland, Australia; School of Nursing, Queensland University of Technology, Brisbane, Queensland, Australia.